Stock Track | CanSino Biologics Soars 5.59% in Morning Session on Malaysia GMP Certification

Stock Track03-06

CanSino Biologics' stock surged 5.59% during Friday's morning trading session.

The sharp increase follows the company's announcement that Malaysia's National Pharmaceutical Regulatory Agency has granted a Good Manufacturing Practice certificate under the Pharmaceutical Inspection Co-Operation Scheme for its vaccine manufacturing site. The certification covers production of the Group ACYW135 meningococcal polysaccharide conjugate vaccine (MCV4) and the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13i).

This regulatory approval is seen as a positive development for the company's manufacturing capabilities and potential market expansion in Southeast Asia.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1109135016?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 10:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109135016","market":"hk","top_or_hot":-1,"title":"Stock Track | CanSino Biologics Soars 5.59% in Morning Session on Malaysia GMP Certification","media":"Stock Track","content":"<p>CanSino Biologics' stock surged 5.59% during Friday's morning trading session.</p><p>The sharp increase follows the company's announcement that Malaysia's National Pharmaceutical Regulatory Agency has granted a Good Manufacturing Practice certificate under the Pharmaceutical Inspection Co-Operation Scheme for its vaccine manufacturing site. The certification covers production of the Group ACYW135 meningococcal polysaccharide conjugate vaccine (MCV4) and the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13i).</p><p>This regulatory approval is seen as a positive development for the company's manufacturing capabilities and potential market expansion in Southeast Asia.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CanSino Biologics Soars 5.59% in Morning Session on Malaysia GMP Certification</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CanSino Biologics Soars 5.59% in Morning Session on Malaysia GMP Certification\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-06 10:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CanSino Biologics' stock surged 5.59% during Friday's morning trading session.</p><p>The sharp increase follows the company's announcement that Malaysia's National Pharmaceutical Regulatory Agency has granted a Good Manufacturing Practice certificate under the Pharmaceutical Inspection Co-Operation Scheme for its vaccine manufacturing site. The certification covers production of the Group ACYW135 meningococcal polysaccharide conjugate vaccine (MCV4) and the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13i).</p><p>This regulatory approval is seen as a positive development for the company's manufacturing capabilities and potential market expansion in Southeast Asia.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06185","symbol_name":"康希诺生物","start_time":0,"source_url":"","article_id":"1109135016","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109135016","pubTimestamp":1772763533,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"CanSino Biologics' stock surged 5.59% during Friday's morning trading session.The sharp increase follows the company's announcement that Malaysia's National Pharmaceutical Regulatory Agency has...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06185":"康希诺生物"},"translate_title":"个股追踪|马GMP认证康希诺生物早盘大涨5.59%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06185":1},"content_text":"CanSino Biologics' stock surged 5.59% during Friday's morning trading session.The sharp increase follows the company's announcement that Malaysia's National Pharmaceutical Regulatory Agency has granted a Good Manufacturing Practice certificate under the Pharmaceutical Inspection Co-Operation Scheme for its vaccine manufacturing site. The certification covers production of the Group ACYW135 meningococcal polysaccharide conjugate vaccine (MCV4) and the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13i).This regulatory approval is seen as a positive development for the company's manufacturing capabilities and potential market expansion in Southeast Asia.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1109135016","isCrawlerRequest":true}